Handmade quality · Free shipping over $75 · Explore the atelier

TAK1/MAP4K2 inhibitor 1 roacetate salt American Journal of Cardiology

SKU: 98545992929

4.8
USD138.00 USD178.00

Pay in 4 interest-free payments of $34.50 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

American Journal of Cardiology

HAMNO inhibits both ATR autophosphorylation and phosphorylation of RPA32 Ser33 by ATR

Ex vivo studies showed that pantoprazole inhibited TOPK activities in JB6 Cl41 cells and HCT 116 colorectal cancer cells

InChi: InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10

Cardiogenol C HCl

TAK1/MAP4K2 inhibitor 1 roacetate salt American Journal of CardiologyTAK1 MAP4K2 inhibitor 1 is a potent dual TGF activated kinase 1 (TAK1) and mitogen activated protein kinase kinase kinase kinase 2 (MAP4K2) inhibitor, with IC50s of 41. 1 nM and 18. 2 nM, respectively. Product information CAS Number: 1315330 11 0 Molecular Weight: 552. 59 Formula: C29H31F3N6O2 Synonym: Benzamide, N [4 [(4 ethyl 1 piperazinyl)methyl] 3 (trifluoromethyl)phenyl] 4 methyl 3 [(6 methyl 7H pyrrolo[2,3 d]pyrimidin 4 yl)oxy] Chemical Name: N

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products